Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study

BACKGROUND: Reliable biomarkers of apatinib response in gastric cancer (GC) are lacking. We investigated the association between early presence of common adverse events (AEs) and clinical outcomes in metastatic GC patients. PATIENTS AND METHODS: We conducted a retrospective cohort study using data o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Liu, Xinyang, Qin, Shukui, Wang, Zhichao, Xu, Jianming, Xiong, Jianping, Bai, Yuxian, Wang, Zhehai, Yang, Yan, Sun, Guoping, Wang, Liwei, Zheng, Leizhen, Xu, Nong, Cheng, Ying, Guo, Weijian, Yu, Hao, Liu, Tianshu, Lagiou, Pagona, Li, Jin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584332/
https://ncbi.nlm.nih.gov/pubmed/28870253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0521-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados